D.A. DAVIDSON & CO. - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$342,000
-37.8%
40,700
-14.6%
0.01%
-36.4%
Q3 2017$550,000
+16.0%
47,650
+17.4%
0.01%0.0%
Q2 2017$474,000
+7.2%
40,600
+13.2%
0.01%0.0%
Q1 2017$442,000
-10.0%
35,850
-0.6%
0.01%0.0%
Q4 2016$491,000
+16266.7%
36,050
+16667.4%
0.01%
Q3 2015$3,000
-25.0%
2150.0%0.00%
Q2 2015$4,0002150.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
RA Capital Management 1,026,402$21,832,0002.20%
Avoro Capital Advisors LLC 262,515$5,584,0001.54%
Lamond Capital Partners LLC 68,780$1,463,0001.48%
Green Owl Capital Management, LLC 90,000$1,914,0001.36%
Baker Brothers Advisors 4,190,594$89,134,0000.78%
SPHERA FUNDS MANAGEMENT LTD. 231,514$4,924,0000.48%
Redmile Group, LLC 238,121$5,065,0000.42%
Highlander Capital Management, LLC 19,250$409,0000.37%
Spark Investment Management LLC 110,500$2,350,0000.33%
EMERALD MUTUAL FUND ADVISERS TRUST 145,380$3,092,0000.24%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders